Clobetasol propionate ophthalmic nanoemulsion (Salvat)

N/A

Report date: 2026/01/08 20:00:10

Base Information

Drug NameClobetasol propionate ophthalmic nanoemulsion (Salvat)
Drug Alias Name丙酸氯倍他索眼用纳米乳剂SVT-15473
ClassificationSmall molecules > Steroids
Mechanisms of ActionSteroid hormone receptor agonists
TargetsSteroid hormone receptor
Therapy Area/IndicationsCataract
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSalvat
China Registration ClassN/A

Develop Information

Active CompaniesSalvat
Inactive CompaniesN/A
Active IndicationsCataract
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A